NASDAQ:NPCE
NeuroPace Inc
NeuroPace Inc's revenue grew 25.1% in fiscal 2025 to $100.0M while operating margin rose to −16.3%, its highest in 6 years. Free cash flow was −$11.3M, −11.3% of revenue, and the diluted share count rose 12.3%.Summary generated from NeuroPace Inc's SEC filings. Latest annual report filed Mar 3, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$100.0M
Revenue growth+25.1%
Revenue, 5-yr CAGR+19.4%
Gross margin77.2%
Operating margin−16.3%
Net margin−21.5%
ROIC−23.4%
Return on equity−158.7%
Debt / equity3.09
Free cash flow−$11.3M
FCF margin−11.3%
Share count change+12.3%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 45 | 46 | 65 | 80 | 100 |
| Operating income | −24 | −41 | −27 | −22 | −16 |
| Net income | −36 | −47 | −33 | −27 | −21 |
| Free cash flow | −25 | −37 | −20 | −18 | −11 |
Recent filings
- 4Insider transaction report
Sep 25, 2026 - 4Insider transaction report
Sep 21, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 11, 2026 - 8-KResults of operations and financial condition
Aug 11, 2026 - 8-KRegulation FD disclosure
Jul 28, 2026 - 8-KResults of a shareholder vote
Jun 8, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 12, 2026 - 8-KResults of operations and financial condition
May 12, 2026